Literature DB >> 7511702

Trophic effects of basic fibroblast growth factor (bFGF) on differentiated oligodendroglia: a mechanism for regeneration of the oligodendroglial lineage.

J B Grinspan1, J L Stern, B Franceschini, D Pleasure.   

Abstract

We have investigated the effect of basic fibroblast growth factor (bFGF) on the proliferation and phenotype of differentiated oligodendroglia. Using primary cell cultures enriched in oligodendrocytes but containing few O2A-oligodendrocyte progenitor cells, we demonstrate that bFGF treatment greatly increases the proportion of O2A cells while decreasing the proportion of galactocerebroside +(GalC+), myelin basic protein +(MBP+) oligodendrocytes, and the steady state levels of MPB mRNA. Complement mediated cell lysis experiments using the A2B5 antibody to deplete existing O2A cells or the R-Mab antibody to deplete existing oligodendroglia show that bFGF elicits a rapid increase in the number of O2A cells in cultures previously depleted of O2A cells, but does not cause an early increase in O2A cells in cultures from which oligodendroglia had been removed, indicating that the oligodendrocytes are the source of the newly recruited O2A cells. This bFGF-mediated transition from oligodendrocyte to O2A cells occurs with a time course similar to the bFGF-induced increase of the proliferation rate of the GalC+ oligodendrocytes. Studies with purified, passaged cells of the oligodendroglial lineage show that bFGF augments oligodendroglial dedifferentiation and proliferation in chronologically adult oligodendrocytes and in the virtual absence of other cell types. We have thus demonstrated that mature oligodendrocytes are induced by bFGF to dedifferentiate and proliferate, suggesting a mechanism for regeneration of the oligodendroglial lineage following demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7511702     DOI: 10.1002/jnr.490360608

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  20 in total

1.  Remyelination in vitro following protein kinase C activator-induced demyelination.

Authors:  S Pouly; J M Matthieu; P Honegger
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

Review 2.  From stem cells to oligodendrocytes: prospects for brain therapy.

Authors:  Cui P Chen; Mary E Kiel; Dorota Sadowski; Randall D McKinnon
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

Review 3.  Do oligodendrocytes divide?

Authors:  W T Norton
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

Review 4.  Cell reactions following acute brain injury: a review.

Authors:  W T Norton
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 5.  Glial lineages and myelination in the central nervous system.

Authors:  A Compston; J Zajicek; J Sussman; A Webb; G Hall; D Muir; C Shaw; A Wood; N Scolding
Journal:  J Anat       Date:  1997-02       Impact factor: 2.610

6.  Transplanted oligodendrocyte progenitor cells expressing a dominant-negative FGF receptor transgene fail to migrate in vivo.

Authors:  D J Osterhout; S Ebner; J Xu; D M Ornitz; G A Zazanis; R D McKinnon
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

7.  CXCR2 signaling protects oligodendrocyte progenitor cells from IFN-γ/CXCL10-mediated apoptosis.

Authors:  Emanuele Tirotta; Richard M Ransohoff; Thomas E Lane
Journal:  Glia       Date:  2011-06-08       Impact factor: 7.452

Review 8.  Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke.

Authors:  Kanako Itoh; Takakuni Maki; Josephine Lok; Ken Arai
Journal:  Brain Res       Date:  2015-05-08       Impact factor: 3.252

Review 9.  Glioma formation, cancer stem cells, and akt signaling.

Authors:  Dolores Hambardzumyan; Massimo Squatrito; Eletha Carbajal; Eric C Holland
Journal:  Stem Cell Rev       Date:  2008-09       Impact factor: 5.739

10.  Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination.

Authors:  K Asakura; D J Miller; L R Pease; M Rodriguez
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.